{
    "clinical_study": {
        "@rank": "84137", 
        "acronym": "HWD", 
        "arm_group": {
            "arm_group_label": "HWD1000", 
            "arm_group_type": "Experimental", 
            "description": "Subjects using HWD1000"
        }, 
        "brief_summary": {
            "textblock": "This study will obtain device-human interaction evaluations for the HWD1000 within the\n      controlled environment of the hospital as well as establish that the safety profile is\n      similar to outpatient wearable cardioverter-defibrillators use."
        }, 
        "brief_title": "Hospital Wearable Defibrillator Inpatient Study", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "In-Hospital Cardiac Arrest", 
        "condition_browse": {
            "mesh_term": "Heart Arrest"
        }, 
        "detailed_description": {
            "textblock": "A multi-center prospective study of hospitalized patients whom a physician deems at risk of\n      sudden cardiac arrest during the hospitalization period, wearing the HWD1000 hospital\n      wearable defibrillator in order to evaluate caregiver and patient interactions with the\n      device. In addition, ECG signal quality will be reviewed to confirm the HWD1000 safety\n      profile."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients whom a physician deems at risk of sudden cardiac arrest during the\n        hospitalization period (patients will be monitored using the hospital's telemetry system).\n        Specific inclusion criteria are:\n\n          -  Hospitalized patients having continuous independent ECG monitoring.\n\n          -  Patients at risk of sudden cardiac arrest during the hospitalization period as\n             determined by the investigating physician.\n\n          -  Patient \u226518 years of age (over the legal age of providing consent).\n\n        Exclusion Criteria:\n\n          -  Patients with an active implantable cardioverter-defibrillator.\n\n          -  Patients with an active unipolar pacemaker.\n\n          -  Patients with physical or mental conditions preventing them from interacting with or\n             wearing the device as determined by the investigating physician.\n\n          -  Patients having an advanced directive prohibiting resuscitation.\n\n          -  Patients having bandages or other clinical condition preventing the HWD use.\n\n          -  Patients unable to consent.\n\n          -  Patients having recently experienced an arrhythmic storm.\n\n          -  Patients prone to paroxysmal supraventricular tachycardia."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02122549", 
            "org_study_id": "90D0118"
        }, 
        "intervention": {
            "arm_group_label": "HWD1000", 
            "description": "Wearable cardioverter-defibrillator designed for inpatient use", 
            "intervention_name": "HWD1000", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "In-Hospital Cardiac Arrest", 
            "Telemetry"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "number_of_arms": "1", 
        "official_title": "Hospital Wearable Defibrillator Inpatient Study", 
        "overall_official": {
            "affiliation": "Zoll Medical Corporation", 
            "last_name": "Steven J Szymkiewicz, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The amount of time that the HWD1000 is unable to effectively monitor the subject's rhythm status is the primary safety measure. The specific goals are that monitoring will be inhibited by noise no greater than 2% of the time worn and monitoring using single lead analysis will be no greater than 5% of the time worn.", 
            "measure": "Percentage of time rhythm monitoring by the HWD1000 is compromised due to ECG noise.", 
            "safety_issue": "Yes", 
            "time_frame": "Device use is expected to average three days."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02122549"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Zoll Medical Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zoll Medical Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}